Clinical Trial

Capillary Blood Accuracy

Study acronym: CAPYBARA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated November 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
Entia is a health technology company that has developed a blood testing device called Entia Liberty, which analyses blood collected by a finger prick. Entia is sponsoring this research study to compare the results from Entia Liberty finger prick tests to results from the gold-standard laboratory analyser that tests blood from the arm, port, or PICC line.
Trial Details
NCT Number NCT06544070
Lead Sponsor Entia Ltd
Conditions Cancer
Enrollment 180 participants
Start Date 2024-11-04
Primary Completion 2025-11-03 (estimated)
Study Completion 2025-11-03 (estimated)
Updated on ClinicalTrials.gov 2024-08-09